[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Oxaliplatin Market Research Report Forecast 2017-2021

May 2017 | 112 pages | ID: E410F43E4FDEN
S&P Consulting

US$ 3,040.00 US$ 3,800.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Europe Oxaliplatin Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Oxaliplatin industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Oxaliplatin market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs

Europe Oxaliplatin Market Analysis by Countries:
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
Sanofi-Aventis
Yakult honsha
Dr Reddy's laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine

Europe Oxaliplatin Market Analysis by Product:
Type 1
Type 2
Type 3

Europe Oxaliplatin Market Analysis by Application:
Reed Relays
Magnetic Sensors
Others

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
1 OXALIPLATIN MARKET OVERVIEW

1.1 Product Overview and Scope of Oxaliplatin
1.2 Classification of Oxaliplatin
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Oxaliplatin
  1.3.2 Reed Relays
  1.3.3 Magnetic Sensors
  1.3.4 Others
1.4 Oxaliplatin Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Oxaliplatin (2012-2021)
  1.5.1 Europe Oxaliplatin Sales and Growth Rate (2012-2021)
  1.5.2 Europe Oxaliplatin Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON OXALIPLATIN INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 OXALIPLATIN MANUFACTURING COST ANALYSIS

3.1 Oxaliplatin Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Oxaliplatin

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Oxaliplatin Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Oxaliplatin Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE OXALIPLATIN MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Oxaliplatin Market Competition by Manufacturers
  5.1.1 Europe Oxaliplatin Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Oxaliplatin Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Oxaliplatin (Volume and Value) by Type
  5.2.1 Europe Oxaliplatin Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Oxaliplatin Revenue and Market Share by Type (2012-2017)
5.3 Europe Oxaliplatin (Volume and Value) by Countries
  5.3.1 Europe Oxaliplatin Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Oxaliplatin Revenue and Market Share by Countries (2012-2017)
5.4 Europe Oxaliplatin (Volume) by Application

6 GERMANY OXALIPLATIN (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Oxaliplatin Sales and Value (2012-2017)
  6.1.1 Germany Oxaliplatin Sales and Growth Rate (2012-2017)
  6.1.2 Germany Oxaliplatin Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Oxaliplatin Sales Price Trend (2012-2017)
6.2 Germany Oxaliplatin Sales and Market Share by Manufacturers
6.3 Germany Oxaliplatin Sales and Market Share by Type
6.4 Germany Oxaliplatin Sales and Market Share by Application

7 FRANCE OXALIPLATIN (VOLUME, VALUE AND SALES PRICE)

7.1 France Oxaliplatin Sales and Value (2012-2017)
  7.1.1 France Oxaliplatin Sales and Growth Rate (2012-2017)
  7.1.2 France Oxaliplatin Revenue and Growth Rate (2012-2017)
  7.1.3 France Oxaliplatin Sales Price Trend (2012-2017)
7.2 France Oxaliplatin Sales and Market Share by Manufacturers
7.3 France Oxaliplatin Sales and Market Share by Type
7.4 France Oxaliplatin Sales and Market Share by Application

8 UK OXALIPLATIN (VOLUME, VALUE AND SALES PRICE)

8.1 UK Oxaliplatin Sales and Value (2012-2017)
  8.1.1 UK Oxaliplatin Sales and Growth Rate (2012-2017)
  8.1.2 UK Oxaliplatin Revenue and Growth Rate (2012-2017)
  8.1.3 UK Oxaliplatin Sales Price Trend (2012-2017)
8.2 UK Oxaliplatin Sales and Market Share by Manufacturers
8.3 UK Oxaliplatin Sales and Market Share by Type
8.4 UK Oxaliplatin Sales and Market Share by Application

9 RUSSIA OXALIPLATIN (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Oxaliplatin Sales and Value (2012-2017)
  9.1.1 Russia Oxaliplatin Sales and Growth Rate (2012-2017)
  9.1.2 Russia Oxaliplatin Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Oxaliplatin Sales Price Trend (2012-2017)
9.2 Russia Oxaliplatin Sales and Market Share by Manufacturers
9.3 Russia Oxaliplatin Sales and Market Share by Type
9.4 Russia Oxaliplatin Sales and Market Share by Application

10 ITALY OXALIPLATIN (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Oxaliplatin Sales and Value (2012-2017)
  10.1.1 Italy Oxaliplatin Sales and Growth Rate (2012-2017)
  10.1.2 Italy Oxaliplatin Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Oxaliplatin Sales Price Trend (2012-2017)
10.2 Italy Oxaliplatin Sales and Market Share by Manufacturers
10.3 Italy Oxaliplatin Sales and Market Share by Type
10.4 Italy Oxaliplatin Sales and Market Share by Application

11 SPAIN OXALIPLATIN (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Oxaliplatin Sales and Value (2012-2017)
  11.1.1 Spain Oxaliplatin Sales and Growth Rate (2012-2017)
  11.1.2 Spain Oxaliplatin Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Oxaliplatin Sales Price Trend (2012-2017)
11.2 Spain Oxaliplatin Sales and Market Share by Manufacturers
11.3 Spain Oxaliplatin Sales and Market Share by Type
11.4 Spain Oxaliplatin Sales and Market Share by Application

12 BENELUX OXALIPLATIN (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Oxaliplatin Sales and Value (2012-2017)
  12.1.1 Benelux Oxaliplatin Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Oxaliplatin Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Oxaliplatin Sales Price Trend (2012-2017)
12.2 Benelux Oxaliplatin Sales and Market Share by Manufacturers
12.3 Benelux Oxaliplatin Sales and Market Share by Type
12.4 Benelux Oxaliplatin Sales and Market Share by Application

13 EUROPE OXALIPLATIN MANUFACTURERS ANALYSIS

13.1 Sanofi-Aventis
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Yakult honsha
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Dr Reddy's laboratories
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Sun Pharmaceutical
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Teva
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Fresenius Kabi
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Hospira
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Mylan
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Jiangsu Hengrui Medicine
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE OXALIPLATIN MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Oxaliplatin Market Forecast by Type (2017-2021)
15.9 Europe Oxaliplatin Market Forecast by Application (2017-2021)

16 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Oxaliplatin
Table Classification of Oxaliplatin
Figure Europe Sales Market Share of Oxaliplatin by Type in 2015
Table Application of Oxaliplatin
Figure Europe Sales Market Share of Oxaliplatin by Application in 2015
Figure Germany Oxaliplatin Revenue and Growth Rate (2012-2021)
Figure France Oxaliplatin Revenue and Growth Rate (2012-2021)
Figure UK Oxaliplatin Revenue and Growth Rate (2012-2021)
Figure Russia Oxaliplatin Revenue and Growth Rate (2012-2021)
Figure Italy Oxaliplatin Revenue and Growth Rate (2012-2021)
Figure Spain Oxaliplatin Revenue and Growth Rate (2012-2021)
Figure Benelux Oxaliplatin Revenue and Growth Rate (2012-2021)
Figure Europe Oxaliplatin Sales and Growth Rate (2012-2021)
Figure Europe Oxaliplatin Revenue and Growth Rate (2012-2021)
Table Europe Oxaliplatin Sales of Key Manufacturers (2015 and 2016)
Table Europe Oxaliplatin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Oxaliplatin Sales Share by Manufacturers
Figure 2016 Oxaliplatin Sales Share by Manufacturers
Table Europe Oxaliplatin Revenue by Manufacturers (2015 and 2016)
Table Europe Oxaliplatin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Oxaliplatin Revenue Share by Manufacturers
Table 2016 Europe Oxaliplatin Revenue Share by Manufacturers
Table Europe Oxaliplatin Sales and Market Share by Type (2012-2017)
Table Europe Oxaliplatin Sales Share by Type (2012-2017)
Figure Sales Market Share of Oxaliplatin by Type (2012-2017)
Figure Europe Oxaliplatin Sales Growth Rate by Type (2012-2017)
Table Europe Oxaliplatin Revenue and Market Share by Type (2012-2017)
Table Europe Oxaliplatin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oxaliplatin by Type (2012-2017)
Figure Europe Oxaliplatin Revenue Growth Rate by Type (2012-2017)
Table Europe Oxaliplatin Sales and Market Share by Countries (2012-2017)
Table Europe Oxaliplatin Sales Share by Countries (2012-2017)
Figure Sales Market Share of Oxaliplatin by Countries (2012-2017)
Table Europe Oxaliplatin Revenue and Market Share by Countries (2012-2017)
Table Europe Oxaliplatin Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Oxaliplatin by Countries (2012-2017)
Table Europe Oxaliplatin Sales and Market Share by Application (2012-2017)
Table Europe Oxaliplatin Sales Share by Application (2012-2017)
Figure Sales Market Share of Oxaliplatin by Application (2012-2017)
Figure Germany Oxaliplatin Sales and Growth Rate (2012-2017)
Figure Germany Oxaliplatin Revenue and Growth Rate (2012-2017)
Figure Germany Oxaliplatin Sales Price Trend (2012-2017)
Table Germany Oxaliplatin Sales by Manufacturers (2015 and 2016)
Table Germany Oxaliplatin Market Share by Manufacturers (2015 and 2016)
Table Germany Oxaliplatin Sales by Type (2015 and 2016)
Table Germany Oxaliplatin Market Share by Type (2015 and 2016)
Table Germany Oxaliplatin Sales by Application (2015 and 2016)
Table Germany Oxaliplatin Market Share by Application (2015 and 2016)
Figure France Oxaliplatin Sales and Growth Rate (2012-2017)
Figure France Oxaliplatin Revenue and Growth Rate (2012-2017)
Figure France Oxaliplatin Sales Price Trend (2012-2017)
Table France Oxaliplatin Sales by Manufacturers (2015 and 2016)
Table France Oxaliplatin Market Share by Manufacturers (2015 and 2016)
Table France Oxaliplatin Sales by Type (2015 and 2016)
Table France Oxaliplatin Market Share by Type (2015 and 2016)
Table France Oxaliplatin Sales by Application (2015 and 2016)
Table France Oxaliplatin Market Share by Application (2015 and 2016)
Figure UK Oxaliplatin Sales and Growth Rate (2012-2017)
Figure UK Oxaliplatin Revenue and Growth Rate (2012-2017)
Figure UK Oxaliplatin Sales Price Trend (2012-2017)
Table UK Oxaliplatin Sales by Manufacturers (2015 and 2016)
Table UK Oxaliplatin Market Share by Manufacturers (2015 and 2016)
Table UK Oxaliplatin Sales by Type (2015 and 2016)
Table UK Oxaliplatin Market Share by Type (2015 and 2016)
Table UK Oxaliplatin Sales by Application (2015 and 2016)
Table UK Oxaliplatin Market Share by Application (2015 and 2016)
Figure Russia Oxaliplatin Sales and Growth Rate (2012-2017)
Figure Russia Oxaliplatin Revenue and Growth Rate (2012-2017)
Figure Russia Oxaliplatin Sales Price Trend (2012-2017)
Table Russia Oxaliplatin Sales by Manufacturers (2015 and 2016)
Table Russia Oxaliplatin Market Share by Manufacturers (2015 and 2016)
Table Russia Oxaliplatin Sales by Type (2015 and 2016)
Table Russia Oxaliplatin Market Share by Type (2015 and 2016)
Table Russia Oxaliplatin Sales by Application (2015 and 2016)
Table Russia Oxaliplatin Market Share by Application (2015 and 2016)
Figure Italy Oxaliplatin Sales and Growth Rate (2012-2017)
Figure Italy Oxaliplatin Revenue and Growth Rate (2012-2017)
Figure Italy Oxaliplatin Sales Price Trend (2012-2017)
Table Italy Oxaliplatin Sales by Manufacturers (2015 and 2016)
Table Italy Oxaliplatin Market Share by Manufacturers (2015 and 2016)
Table Italy Oxaliplatin Sales by Type (2015 and 2016)
Table Italy Oxaliplatin Market Share by Type (2015 and 2016)
Table Italy Oxaliplatin Sales by Application (2015 and 2016)
Table Italy Oxaliplatin Market Share by Application (2015 and 2016)
Figure Spain Oxaliplatin Sales and Growth Rate (2012-2017)
Figure Spain Oxaliplatin Revenue and Growth Rate (2012-2017)
Figure Spain Oxaliplatin Sales Price Trend (2012-2017)
Table Spain Oxaliplatin Sales by Manufacturers (2015 and 2016)
Table Spain Oxaliplatin Market Share by Manufacturers (2015 and 2016)
Table Spain Oxaliplatin Sales by Type (2015 and 2016)
Table Spain Oxaliplatin Market Share by Type (2015 and 2016)
Table Spain Oxaliplatin Sales by Application (2015 and 2016)
Table Spain Oxaliplatin Market Share by Application (2015 and 2016)
Figure Benelux Oxaliplatin Sales and Growth Rate (2012-2017)
Figure Benelux Oxaliplatin Revenue and Growth Rate (2012-2017)
Figure Benelux Oxaliplatin Sales Price Trend (2012-2017)
Table Benelux Oxaliplatin Sales by Manufacturers (2015 and 2016)
Table Benelux Oxaliplatin Market Share by Manufacturers (2015 and 2016)
Table Benelux Oxaliplatin Sales by Type (2015 and 2016)
Table Benelux Oxaliplatin Market Share by Type (2015 and 2016)
Table Benelux Oxaliplatin Sales by Application (2015 and 2016)
Table Benelux Oxaliplatin Market Share by Application (2015 and 2016)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Oxaliplatin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi-Aventis Oxaliplatin Sales Market Share (2012-2017)
Table Yakult honsha Basic Information List
Table Yakult honsha Oxaliplatin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Yakult honsha Oxaliplatin Sales Market Share (2012-2017)
Table Dr Reddy's laboratories Basic Information List
Table Dr Reddy's laboratories Oxaliplatin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Dr Reddy's laboratories Oxaliplatin Sales Market Share (2012-2017)
Table Sun Pharmaceutical Basic Information List
Table Sun Pharmaceutical Oxaliplatin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sun Pharmaceutical Oxaliplatin Sales Market Share (2012-2017)
Table Teva Basic Information List
Table Teva Oxaliplatin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Teva Oxaliplatin Sales Market Share (2012-2017)
Table Fresenius Kabi Basic Information List
Table Fresenius Kabi Oxaliplatin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Fresenius Kabi Oxaliplatin Sales Market Share (2012-2017)
Table Hospira Basic Information List
Table Hospira Oxaliplatin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hospira Oxaliplatin Sales Market Share (2012-2017)
Table Mylan Basic Information List
Table Mylan Oxaliplatin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Mylan Oxaliplatin Sales Market Share (2012-2017)
Table Jiangsu Hengrui Medicine Basic Information List
Table Jiangsu Hengrui Medicine Oxaliplatin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Jiangsu Hengrui Medicine Oxaliplatin Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oxaliplatin
Figure Manufacturing Process Analysis of Oxaliplatin
Figure Oxaliplatin Industrial Chain Analysis
Table Raw Materials Sources of Oxaliplatin Major Manufacturers in 2015
Table Major Buyers of Oxaliplatin
Table Distributors/Traders List
Figure Germany Oxaliplatin Sales and Growth Rate Forecast (2017-2021)
Figure Germany Oxaliplatin Revenue and Growth Rate Forecast (2017-2021)
Figure France Oxaliplatin Sales and Growth Rate Forecast (2017-2021)
Figure France Oxaliplatin Revenue and Growth Rate Forecast (2017-2021)
Figure UK Oxaliplatin Sales and Growth Rate Forecast (2017-2021)
Figure UK Oxaliplatin Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Oxaliplatin Sales and Growth Rate Forecast (2017-2021)
Figure Russia Oxaliplatin Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Oxaliplatin Sales and Growth Rate Forecast (2017-2021)
Figure Italy Oxaliplatin Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Oxaliplatin Sales and Growth Rate Forecast (2017-2021)
Figure Spain Oxaliplatin Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Oxaliplatin Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Oxaliplatin Revenue and Growth Rate Forecast (2017-2021)
Table Europe Oxaliplatin Sales Forecast by Type (2017-2021)
Table Europe Oxaliplatin Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

Sanofi-Aventis
Yakult honsha
Dr Reddy's laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
Jari Pharmaceutical
Chiatai Tianqing


More Publications